LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Valerie W. McClain, IBCLC" <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Tue, 20 Mar 2001 06:30:05 EST
Content-Type:
text/plain
Parts/Attachments:
text/plain (25 lines)
For those who have a difficult time believeing that Martek is genetically
engineering the microalgae (DHA) I have one of the company's information
releases dated 1997 by the menu but dated 1998 in the release itself.
Valerie W. McClain, IBCLC

http://www.martekbio.com/980309.html

COLUMBIA, MD, MARCH 9, 1998 -- Martek Biosciences Corporation (NASDAQ: MATK)
today announced that the National Science Foundation (NSF) has awarded the
Company a Phase II Small Business Innovation Research (SBIR) grant to develop
technology for the genetic transformation of microalgae. This research could
set the stage for the use of molecular technology in the development of
commercially important products from microalgae. Martek will be assisted by
the Carnegie Institution of Washington, Plant Biology Division.

"This NSF grant should help advance microalgal technology," said Henry
Linsert, Jr., Martek's Chairman and CEO. "This is not only important to
science but also future commercial products and processes."

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2